bipolar disorder Archives -

BioXcel Therapeutics has claimed its first product approval, getting a green light from the FDA for Igalmi as

BioXcel gets first approval for agitation drug Igalmi

https://pharmaphorum.com/news/bioxcel-gets-first-approval-for-agitation-drug-igalmi/

The FDA approval of Alkermes’ new antipsychotic drug Lybalvi couldn’t have gone any better for the company, but

After FDA approval, Alkermes plans soft launch for antipsychotic Lybalvi

https://pharmaphorum.com/news/after-fda-approval-alkermes-plans-soft-launch-for-antipsychotic-lybalvi/

A sublingual film for acute agitation in schizophrenia and bipolar disorder from BioXcel has blockbuster potential that could

BioXcel’s phase 3 schizophrenia film has blockbuster potential, say analysts

https://pharmaphorum.com/news/bioxcel/

Companies want Vraylar as option bipolar depression

Allergan and Gedeon Richter set to expand use of bipolar drug

https://pharmaphorum.com/news/allergangedeon-richter-aim-expand-use-bipolar-drug/

Depakine and generics linked with defects including spina bifida.

Report links Sanofi epilepsy drug with thousands of birth defects

https://pharmaphorum.com/news/report-links-sanofi-epilepsy-drug-thousands-birth-defects/

Companies want new bipolar disorder use for Abilify Maintena.

Lundbeck/Otsuka look for new use of mental health drug

https://pharmaphorum.com/news/lundbeckotsuka-look-new-use-mental-health-drug/

bipolar disorder